- Science Immunology, 2023: Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
- Science Translational Medicine, 2023: Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer
- Journal For ImmunoTherapy of Cancer, 2022: First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
- Nature Medicine, 2021: Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
